Tablet Scoring:Nomenclature, Labeling, and Data for Evaluation
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
March 13, 2013
May 5, 2020
d4b6bb69-1a24-4ebd-be2e-a80b08473b39
Related Documents
Residual Drug in Transdermal and Related Drug Delivery Systems: Guidance for Industry
Guidance DocumentAugust 17, 2011Center for Drug Evaluation and Research
ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers
Guidance DocumentMay 15, 2014Center for Drug Evaluation and Research
ANDAs: Stability Testing of Drug Substances and Products
Guidance DocumentJune 20, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox